GlaxoSmithKline PLC (GSK) Financial News - Glaxo Halts Resveratrol Study
GlaxoSmithKline PLC (GSK)
Glaxo Halts Resveratrol Study
2010-05-06 04:40:26
Keywords: Glaxo Smith Kline resveratrol, multiple myeloma study, Sirtris Pharmaceuticals
Quote: GlaxoSmithKline (GSK) halted a clinical trial seeking toexplore the benefits of a chemical found in red wine.The trial was studying the effects on cancer patients of a drug containing a reformulated version of resveratrol. Glaxoacquired the drug as part of its 2008 purchase of Sirtris Pharmaceuticals.Glaxo halted its trial of the drug on patients with multiple myeloma after several patients developed nephropathy,a condition that can cause kidney failure.A Sirtris official told Dow Jones that the condition is common in multiple myeloma patients, so its cause is unclear.Resveratrol has been hailed as an anti-aging miracle drug, but recently scientists have begun to question the effectiveness.Resveratrol is thought to work by activating enzymes in the body called sirtuins....
Open whole article (external link)
Other Financial and Stock Market News concerning GlaxoSmithKline PLC
GlaxoSmithKline PLC Stock Summary
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. It operates in two segments, Pharmaceutical and Consumer Healthcare. The Pharmaceutical segment offers prescription medicines in the therapeutic areas, such as respiratory, central nervous system, anti-virals, anti-bacterials, metabolic, vaccines, cardiovascular and urogenital, oncology, emesis, and dermatology. This segment markets approximately 25 vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment offers OTC medicines, such as alli, a weight loss medicine; Panadol, a paracetamol/acetaminophen analgesic; smoking control products under the NicoDerm, NiQuitin CQ, Nicabate, and Nicorette names; and other brands, including Breathe Right nasal strips, Tums, Citrucel, Contac, and FiberChoice. Its oral healthcare products comprise Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; Sensodyne, a range of toothpastes and toothbrushes, including Pronamel to protect from acid erosion; Biotene, a treatment for dry mouth; Polident, PoliGrip, and Corega, the denture care cleansers and adhesives; and other brands, including Odol, Macleans, and Dr Best. This segment also provides nutritional healthcare products, such as Lucozade, a range of energy and sports drinks; Horlicks, a range of milk-based malted food and chocolate drinks; and Ribena, a blackcurrant juice-based drink. GlaxoSmithKline operates in the United States, Europe, Japan, the Asia Pacific, the Middle East, Latin America, Africa, and Canada. The company was founded in 1935 and is based in Brentford, the United Kingdom.
